You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Its tests use FTIR to measure the spectra from biochemical changes in peripheral blood mononuclear cells, along with a proprietary technique that analyzes results.
The developers hope that the NSCLC detection system they are developing could eventually be expanded to include biomarkers for other cancer types and diseases.
The test, which could be available to clinicians within a year as a lab-developed test, could elevate saliva as a more popular sample medium.
The group said that progress in developing the test for a broad range of medical conditions will be driven in part by frequent donations of urine samples.
In a study, the researchers used patients' blood plasma and infrared spectroscopy to diagnose dementias, and differentiate different forms of the condition from each other.
The present prototype is being expanded to use five liver cancer markers instead of one, and the researchers are developing it to detect other diseases.
The agreement is to support the company’s analytical and preanalytical research and assist in its trials aimed at a number of cancers.
By pressing on a piece of paper, a user could power up the test and potentially apply it in a remote location, the researchers said.
During a clinical study, a positive antimicrobial stewardship outcome emerged in 74 percent of cases where the firm's test provided a rule-out result for sepsis.
A proof-of-concept assay that uses an inkjet-printed nanoscale film achieved performance comparable to that of a laboratory ELISA while testing for leptin.